Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

ICAM-1 nanoclusters regulate hepatic epithelial cell polarity by leukocyte adhesion-independent control of apical actomyosin

  • Cacho Navas, Cristina
  • López Pujante, Carmen
  • Reglero Real, Natalia
  • Colás Algora, Natalia
  • Cuervo, Ana
  • Conesa, Jose Javier
  • Barroso, Susana
  • de Rivas, Gema
  • Ciordia, Sergio
  • Paradela, Alberto
  • D'Agostino, Gianluca
  • Manzo, Carlo
  • Feito, Jorge
  • Andrés, Germán
  • Molina Jiménez, Francisca
  • Majano Rodríguez, Pedro Lorenzo
  • Correas, Isabel
  • Carazo, José Maria
  • Nourshargh, Sussan
  • Huch, Meritxell
  • Millán, Jaime
Epithelial intercellular adhesion molecule (ICAM)-1 is apically polarized, interacts with, and guides leukocytes across epithelial barriers. Polarized hepatic epithelia organize their apical membrane domain into bile canaliculi and ducts, which are not accessible to circulating immune cells but that nevertheless confine most of ICAM-1. Here, by analyzing ICAM-1_KO human hepatic cells, liver organoids from ICAM-1_KO mice and rescue-of-function experiments, we show that ICAM-1 regulates epithelial apicobasal polarity in a leukocyte adhesion-independent manner. ICAM-1 signals to an actomyosin network at the base of canalicular microvilli, thereby controlling the dynamics and size of bile canalicular-like structures. We identified the scaffolding protein EBP50/NHERF1/SLC9A3R1, which connects membrane proteins with the underlying actin cytoskeleton, in the proximity interactome of ICAM-1. EBP50 and ICAM-1 form nano-scale domains that overlap in microvilli, from which ICAM-1 regulates EBP50 nano-organization. Indeed, EBP50 expression is required for ICAM-1-mediated control of BC morphogenesis and actomyosin. Our findings indicate that ICAM-1 regulates the dynamics of epithelial apical membrane domains beyond its role as a heterotypic cell–cell adhesion molecule and reveal potential therapeutic strategies for preserving epithelial architecture during inflammatory stress.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation

  • Cobo, Isidoro
  • Paliwal, Sumit
  • Bodas, Cristina
  • Felipe, Irene
  • Melià-Alomà, Júlia
  • Torres, Ariadna
  • Martínez-Villarreal, Jaime
  • Malumbres, Marina
  • García, Fernando
  • Millán, Irene
  • Del Pozo, Natalia
  • Park, Joo-Cheol
  • MacDonald, Ray J.
  • Muñoz, Javier
  • Méndez, Raúl
  • Real, Francisco X.
Pancreatic acinar cells rely on PTF1 and other transcription factors to deploy their transcriptional program. We identify NFIC as a NR5A2 interactor and regulator of acinar differentiation. NFIC binding sites are enriched in NR5A2 ChIP-Sequencing peaks. Nfic knockout mice have a smaller, histologically normal, pancreas with reduced acinar gene expression. NFIC binds and regulates the promoters of acinar genes and those involved in RNA/protein metabolism, and Nfic knockout pancreata show defective ribosomal RNA maturation. NFIC dampens the endoplasmic reticulum stress program through binding to gene promoters and is required for resolution of Tunicamycin-mediated stress. NFIC is down-regulated during caerulein pancreatitis and is required for recovery after damage. Normal human pancreata with low levels of NFIC transcripts display reduced expression of genes down-regulated in Nfic knockout mice. NFIC expression is down-regulated in mouse and human pancreatic ductal adenocarcinoma. Consistently, Nfic knockout mice develop a higher number of mutant Kras-driven pre-neoplastic lesions., This work was supported, in part, by grants SAF2011-29530, SAF2015-70553-R, RTI2018-101071-B-I00 from Ministerio de Ciencia, Innovación y Universidades (Madrid, Spain) (co-funded by the ERDF-EU) and RTICC from Instituto de Salud Carlos III (RD12/0036/0034) to FXR and grants PID2020-119533GB-I00, from Ministerio de Ciencia, Innovación y Universidades (Madrid, Spain), and GCB15152955MÉND, from the Spanish Association Against Cancer (AECC), to RM. I.C. was recipient of a Beca de Formación del Personal Investigador from Ministerio de Economía y Competitividad (Madrid, Spain). The research leading to these results has received funding from People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007-2013) (REA grant agreement n° 608765”). S.P. was supported by a Juan de la Cierva Programme fellowship from Ministerio de Ciencia, Innovación y Universidades. C.B. is supported by a FPI Fellowship from Ministerio de Ciencia, Innovación y Universidades. I.M. was supported by a Fellowship from Fundació Bancària La Caixa (ID 100010434) (grant number LCF/BQ/ES18/11670009). CNIO is supported by Ministerio de Ciencia, Innovación y Universidades as a Centro de Excelencia Severo Ochoa SEV-2015-0510.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi‑ancestry meta‑analysis

  • Kanoni, Stavroula
  • Cañadas Garre, Marisa
Background: Genetic variants within nearly 1000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. Results: To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry metaanalysis (N = 1,654,960) of blood lipids to prioritize putative causal genes for 2286 lipid associations using six gene prediction approaches. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3–5% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Conclusions: Taken together, our findings provide insights into the biological mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk., United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Heart Lung & Blood Institute (NHLBI) R01HL127564 R01HL142711, Wellcome Trust 201543/B/16/Z 202802/Z/16/Z, European Commission HEALTH-F2-2013-601456 608765 786833, TriPartite Immunometabolism Consortium [TrIC]-Novo Nordisk Foundation NNF15CC0018486, American Diabetes Association 1-19-ICTS-068, Academy of Finland 312062 Finnish Foundation for Cardiovascular Research, Sigrid Juselius Foundation, Finnish innovation fund Sitra (EW) Finska Lakaresallskapet, American Heart Association 15POST24470131 17POST33650016, University of Bristol NIHR Biomedical Research Centre BRC-1215-2001, MRC & WT 217065/Z/19/Z, UK Research & Innovation (UKRI), Medical Research Council UK (MRC) MC_UU_00011, CRUK Integrative Cancer Epidemiology Programme C18281/A19169, UK Research & Innovation (UKRI), Medical Research Council UK (MRC) MC_UU_00011/1, UK National Institute for Health Research Academic Clinical Fellowship, American Heart Association 18CDA34110116, Miguel Servet contract from the ISCIII Spanish Health Institute CP17/00142, European Social Fund (ESF), Westlake Education Foundation, British Heart Foundation FS/14/66/3129 Z01HG200362 R01HL142302 R01HL105756
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST5 ) in pituitary and pancreatic neuroendocrine tumors

  • Pedraza-Arévalo, Sergio
  • Ibáñez-Costa, Alejandro
  • Blázquez-Encinas, Ricardo
  • Branco, Miguel R.
  • Vázquez-Borrego, Mari C.
  • Herrera-Martínez, Aura D.
  • Venegas Moreno, Eva
  • Serrano-Blanch, Raquel
  • Arjona-Sánchez, Álvaro
  • Gálvez-Moreno, María Ángeles
  • Korbonits, Marta
  • Soto-Moreno, Alfonso
  • Gahete, Manuel D.
  • Charalambous, Marika
  • Luque, Raúl M.
  • Castaño, Justo P.
Somatostatin receptor subtype 5 (SST5 ) is an emerging biomarker and actionable target in pituitary (PitNETs) and pancreatic (PanNETs) neuroendocrine tumors. Transcriptional and epigenetic regulation of SSTR5 gene expression and mRNA biogenesis is poorly understood. Recently, an overlapping natural antisense transcript, SSTR5-AS1, potentially regulating SSTR5 expression, was identified. We aimed to elucidate whether epigenetic processes contribute to the regulation of SSTR5 expression in PitNETs (somatotropinomas) and PanNETs. We analyzed the SSTR5/SSTR5-AS1 human locus in silico to identify CpG islands. SSTR5 and SSTR5-AS1 expression was assessed by quantitative real-time PCR (qPCR) in 27 somatotropinomas, 11 normal pituitaries (NPs), and 15 PanNETs/paired adjacent (control) samples. We evaluated methylation grade in four CpG islands in the SSTR5/SSTR5-AS1 genes. Results revealed that SSTR5 and SSTR5-AS1 were directly correlated in NP, somatotropinoma, and PanNET samples. Interestingly, selected CpG islands were differentially methylated in somatotropinomas compared with NPs. In PanNETs cell lines, SSTR5-AS1 silencing downregulated SSTR5 expression, altered aggressiveness features, and influenced pasireotide response. These results provide evidence that SSTR5 expression in PitNETs and PanNETs can be epigenetically regulated by the SSTR5-AS1 antisense transcript and, indirectly, by DNA methylation, which may thereby impact tumor behavior and treatment response., This research was funded by Junta de Andalucía (BIO-0139, P20_00442; PEER-0048-2020); Spanish Ministry of Economy (BFU2016-80360-R), Ministry of Science and Innovation (PID2019-105201RB-I00, PID2019-105564RB-I00); and ISCIII (PI16-00264, CD19/00255), co-funded with EU funds from FEDER Program. People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under project WHRI-ACADEMY, REA grant agreement n° 608765; MECD (FPU14/04290, FPU18/02275); EMBO (short term fellowship 6802); GETNE G2019 Research Grant; Fundación Eugenio Rodriguez Pascual (FERP2019); project grants from the UK Medical Research Council (MR/R022836/1; MR/L002345/1); and CIBERobn; CIBER Fisiopatología de la Obesidad y Nutriciín is an initiative of Instituto de Salud Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function

  • Cuesta-Hernández, Hipólito Nicolás
  • Contreras, Julia
  • Soriano-Maldonado, Pablo
  • Sánchez-Wandelmer, Jana
  • Yeung, Wayland
  • Martín-Hurtado, Ana
  • Muñoz, Inés G.
  • Kannan, Natarajan
  • Llimargas, Marta
  • Muñoz, Javier
  • Plaza-Menacho, Iván
Autophosphorylation controls the transition between discrete functional and conformational states in protein kinases, yet the structural and molecular determinants underlying this fundamental process remain unclear. Here we show that c-terminal Tyr 530 is a de facto c-Src autophosphorylation site with slow time-resolution kinetics and a strong intermolecular component. On the contrary, activation-loop Tyr 419 undergoes faster kinetics and a cis-to-trans phosphorylation switch that controls c-terminal Tyr 530 autophosphorylation, enzyme specificity, and strikingly, c-Src non-catalytic function as a substrate. In line with this, we visualize by X-ray crystallography a snapshot of Tyr 530 intermolecular autophosphorylation. In an asymmetric arrangement of both catalytic domains, a c-terminal palindromic phospho-motif flanking Tyr 530 on the substrate molecule engages the G-loop of the active kinase adopting a position ready for entry into the catalytic cleft. Perturbation of the phospho-motif accounts for c-Src dysfunction as indicated by viral and colorectal cancer (CRC)-associated c-terminal deleted variants. We show that c-terminal residues 531 to 536 are required for c-Src Tyr 530 autophosphorylation, and such a detrimental effect is caused by the substrate molecule inhibiting allosterically the active kinase. Our work reveals a crosstalk between the activation and c-terminal segments that control the allosteric interplay between substrate- and enzyme-acting kinases during autophosphorylation., The authors would like to thank Diamond Light Source for beamtime (beamline B21, proposal mx30297) and the ALBA Synchrotron Light Facility (XALOC-BL13 beamtime, proposal 2020094499) and their staff for assistance during data collection. We thank the Centro Nacional de Investigaciones Oncológicas (CNIO), which is supported by the Instituto de Salud Carlos III and recognized as a “Severo Ochoa” Centre of Excellence (ref. CEX2019-000891-S, awarded by MCIN/AEI/ 10.13039/5 01100011033) for core funding and supporting this study. This work was further supported by projects: grant PGC2018-098449-B-I00 (M.L.) by Spanish Ministerio de Ciencia e Innovación (MCIN), BFU2017-86710-R funded by MCIN/AEI /10.13039/501100011033 and ERDF “A way of making Europe”, PID2020-117580RB-I00 funded by MCIN/ AEI /10.13039/501100011033, RYC-2016-1938 funded by MCIN/AEI /10.13039/501100011033 and ESF “Investing in your future”, and a Marie Curie WHRI-ACADEMY International grant (number 608765) to I.P.-M. FP7-PEOPLE-2013-COFUND - Marie-Curie Action: “Co-funding of regional, National and International Programmes” International grant (number 608765) to I.P.-M. and BES-2017 (ref: EV-2015-0510-17-3) grant from Agencia Estatal de Investigación to I.P.-M. and H.N.C.-H., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000891-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TET2 Regulates the Neuroinflammatory Response in Microglia

  • Carrillo-Jiménez, Alejandro
  • Deniz, Özgen
  • Niklison-Chirou, Maria Victoria
  • Ruiz, Rocío
  • Bezerra-Salomão, Karina
  • Stratoulias, Vassilis
  • Amouroux, Rachel
  • Yip, Ping Kei
  • Vilalta, Anna
  • Cheray, Mathilde
  • Scott-Egerton, Alexander Michael
  • Rivas Infante, Eloy
  • Tayara, Khadija
  • García-Domínguez, Irene
  • García-Revilla, Juan
  • Fernández-Martín, Juan Carlos
  • Espinosa-Oliva, Ana M.
  • Shen, Xianli
  • St George-Hyslop, Peter
  • Brown, Guy Charles
  • Hajkova, Petra
  • Joseph, Bertrand
  • Venero, José L.
  • Branco, Miguel R.
  • Burguillos, Miguel Ángel
Epigenomic mechanisms regulate distinct aspects of the inflammatory response in immune cells. Despite the central role for microglia in neuroinflammation and neurodegeneration, little is known about their epigenomic regulation of the inflammatory response. Here, we show that Ten-eleven translocation 2 (TET2) methylcytosine dioxygenase expression is increased in microglia upon stimulation with various inflammogens through a NF-κB-dependent pathway. We found that TET2 regulates early gene transcriptional changes, leading to early metabolic alterations, as well as a later inflammatory response independently of its enzymatic activity. We further show that TET2 regulates the proinflammatory response in microglia of mice intraperitoneally injected with LPS. We observed that microglia associated with amyloid β plaques expressed TET2 in brain tissue from individuals with Alzheimer's disease (AD) and in 5xFAD mice. Collectively, our findings show that TET2 plays an important role in the microglial inflammatory response and suggest TET2 as a potential target to combat neurodegenerative brain disorders., A.C.-J. is supported by a pre-doctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte. Ö.D. has received funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007-2013) under REA grant agreement 608765. M.V.N.-C. received a Children with Cancer UK fellowship (14-178). This work was supported by grants from Blizard Research Theme grants Queen Mary University of London; Blizard Institute; Spanish Ministerio de Ciencia, Innovación y Universidades/FEDER/UE RTI2018-098645-B-100; Swedish Research Council; ERA-NET TracInflam; Swedish Brain Foundation; and Karolinska Institutet Foundations. M.R.B. is a Sir Henry Dale Fellow (101225/Z/13/Z), jointly funded by the Wellcome Trust and the Royal Society. M.A.B. has been funded by the Barts Charity Centre for Trauma Sciences (C4TS), the Wellcome Trust Institutional Strategic Support Fund (ISSF), and the Spanish Ministry of Economy and Competitivity (Programa Ramón y Cajal: RYC-2017-21804)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effects of dry-cured ham rich in bioactive peptides on cardiovascular health: A randomized controlled trial

  • Montoro García, Silvia
  • Zafrilla Rentero, María Pilar
  • Celdrán-de Haro, Francisco Miguel
  • Piñero-de Armas, Juan José
  • Toldrá Vilardell, Fidel
  • Tejada Portero, Luis
  • Abellán Alemán, José
Establishing health effects of bioactive compounds from dry-cured meat is an active area of clinical research. The present study aims to investigate whether consuming dry-cured ham with biopeptides, among other bioactive compounds, modifies blood pressure (BP) and improves other risk factors for cardiovascular disease in humans. This two-arm, cross-over, randomised controlled trial involved 38 healthy subjects with pre-hypertension. Participants received 80 g/day dry-cured pork ham or 100 g/day cooked ham (control product). A daily intake of 80 g dry-cured ham did not impair BP or 24 h sodium excretion. Total cholesterol, LDL and basal glucose levels dropped after dry-cured ham consumption (p = 0.00019, p = 0.021 and p = 0.014, respectively). Cooked ham did not affect any of the clinical and biochemical markers. Dry-cured ham components could exert a plethora of activities over the cardiovascular system including lipid and glucose metabolism. Additional studies are needed to confirm the effects of dry-cured meat biopeptides on diverse risk factors in pathological conditions., The research reported in this article was supported by the Projects BACCHUS (FP7-KBBE-2012-6-single stage, European Commission Grant Agreement 312090). SMG was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement n° 608765., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis

  • Kanoni, S.
  • Graham, S. E.
  • Wang, Y.
  • Surakka, I.
  • Ramdas, S.
  • Zhu, X.
  • Clarke, S. L.
  • Bhatti, K. F.
  • Vedantam, S.
  • Winkler, T. W.
  • Locke, A. E.
  • Marouli, E.
  • Zajac, G. J. M.
  • Wu, K.H. H.
  • Ntalla, I.
  • Hui, Q.
  • Klarin, D.
  • Hiliard, A.T.
  • Wang, Z.
  • Xue, Ch.
  • Thorleidson, G.
  • Helgadottir, A.
  • Gudbjartsson, D. F.
  • Holm, H.
  • Olafsson, I.
  • Hwang, M. Y.: Han, S.
  • Akiyama, M.
  • Sakue, S.
  • Terao, S.
  • Kanai, M.
  • Zhou, W.
  • Brumpton, B. M.
  • Rasheed, H.
  • Havulinna, A. S.
  • Veturi, Y.
  • Ramírez, J.
Background: Genetic variants within nearly 1000 loci are known to contribute to modulation of blood lipid levels. However, the biological pathways underlying these associations are frequently unknown, limiting understanding of these findings and hindering downstream translational efforts such as drug target discovery. Results: To expand our understanding of the underlying biological pathways and mechanisms controlling blood lipid levels, we leverage a large multi-ancestry meta-analysis (N = 1,654,960) of blood lipids to prioritize putative causal genes for 2286 lipid associations using six gene prediction approaches. Using phenome-wide association (PheWAS) scans, we identify relationships of genetically predicted lipid levels to other diseases and conditions. We confirm known pleiotropic associations with cardiovascular phenotypes and determine novel associations, notably with cholelithiasis risk. We perform sex-stratified GWAS meta-analysis of lipid levels and show that 3-5% of autosomal lipid-associated loci demonstrate sex-biased effects. Finally, we report 21 novel lipid loci identified on the X chromosome. Many of the sex-biased autosomal and X chromosome lipid loci show pleiotropic associations with sex hormones, emphasizing the role of hormone regulation in lipid metabolism. Conclusions: Taken together, our findings provide insights into the biological mechanisms through which associated variants lead to altered lipid levels and potentially cardiovascular disease risk.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genomic and pleiotropic analyses of resting QT interval identifies novel loci and overlap with atrial electrical disorders

  • van Duijvenboden, Stefan
  • Ramírez, Julia
  • Young, William J
  • Orini, Michele
  • Mifsud, Borbala
  • Tinker, Andrew
  • Lambiase, Pier D
  • Munroe, Patricia B
The resting QT interval, an electrocardiographic (ECG) measure of ventricular myocardial repolarization, is a heritable risk marker of cardiovascular mortality, but the mechanisms remain incompletely understood. Previously reported candidate genes have provided insights into the regulatory mechanisms of the QT interval. However, there are still important knowledge gaps. We aimed to gain new insights by (i) providing new candidate genes, (ii) identifying pleiotropic associations with other cardiovascular traits, and (iii) scanning for sexually dimorphic genetic effects. We conducted a genome-wide association analysis for resting QT interval with ~9.8 million variants in 52 107 individuals of European ancestry without known cardiovascular disease from the UK Biobank. We identified 40 loci, 13 of which were novel, including 2 potential sex-specific loci, explaining ~11% of the trait variance. Candidate genes at novel loci were involved in myocardial structure and arrhythmogenic cardiomyopathy. Investigation of pleiotropic effects of QT interval variants using phenome-wide association analyses in 302 000 unrelated individuals from the UK Biobank and pairwise genome-wide comparisons with other ECG and cardiac imaging traits revealed genetic overlap with atrial electrical pathology. These findings provide novel insights into how abnormal myocardial repolarization and increased cardiovascular mortality may be linked.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Genome-wide association study identifies loci for arterial stiffness index in 127,121 UK Biobank participants

  • Fung, Kenneth
  • Ramírez, Julia
  • Warren, Helen R.
  • Aung, Nay
  • Lee, Aaron M.
  • Tzanis, Evan
  • Petersen, Steffen E.
  • Munroe, Patricia B.
Arterial stiffness index (ASI) is a non-invasive measure of arterial stiffness using infra-red finger sensors (photoplethysmography). It is a well-suited measure for large populations as it is relatively inexpensive to perform, and data can be acquired within seconds. These features raise interest in using ASI as a tool to estimate cardiovascular disease risk as prior work demonstrates increased arterial stiffness is associated with elevated systolic blood pressure, and ASI is predictive of cardiovascular disease and mortality. We conducted genome-wide association studies (GWASs) for ASI in 127,121 UK Biobank participants of European-ancestry. Our primary analyses identified variants at four loci reaching genome-wide significance (P < 5 × 10−8): TEX41 (rs1006923; P = 5.3 × 10−12), FOXO1 (rs7331212; P = 2.2 × 10−11), C1orf21 (rs1930290, P = 1.1 × 10−8) and MRVI1 (rs10840457, P = 3.4 × 10−8). Gene-based testing revealed three significant genes, the most significant gene was COL4A2 (P = 1.41 × 10−8) encoding type IV collagen. Other candidate genes at associated loci were also involved in smooth muscle tone regulation. Our findings provide new information for understanding the development of arterial stiffness.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Thirty loci identified for heart rate response to exercise and recovery implicate autonomic nervous system

  • Ramírez, Julia
  • Duijvenboden, Stefan van
  • Ntalla, Ioanna
  • Mifsud, Borbala
  • Warren, Helen R
  • Tzanis, Evan
  • Orini, Michele
  • Tinker, Andrew
  • Lambiase, Pier D.
  • Munroe, Patricia B.
Impaired capacity to increase heart rate (HR) during exercise (ΔHRex), and a reduced rate of recovery post-exercise (ΔHRrec) are associated with higher cardiovascular mortality rates. Currently, the genetic basis of both phenotypes remains to be elucidated. We conduct genome-wide association studies (GWASs) for ΔHRex and ΔHRrec in ~40,000 individuals, followed by replication in ~27,000 independent samples, all from UK Biobank. Six and seven single-nucleotide polymorphisms for ΔHRex and ΔHRrec, respectively, formally replicate. In a full data set GWAS, eight further loci for ΔHRex and nine for ΔHRrec are genome-wide significant (P ≤ 5 × 10−8). In total, 30 loci are discovered, 8 being common across traits. Processes of neural development and modulation of adrenergic activity by the autonomic nervous system are enriched in these results. Our findings reinforce current understanding of HR response to exercise and recovery and could guide future studies evaluating its contribution to cardiovascular risk prediction.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation

  • Cobo, Isidoro
  • Paliwal, Sumit
  • Bodas, Cristina
  • Felipe, Irene
  • Melià-Alomà, Júlia
  • Torres, Ariadna
  • Martínez-Villarreal, Jaime
  • Malumbres, Marina
  • García, Fernando
  • Millán, Irene
  • Del Pozo, Natalia
  • Park, Joo-Cheol
  • MacDonald, Ray J.
  • Muñoz, Javier
  • Méndez, Raúl
  • Real, Francisco X.
Pancreatic acinar cells rely on PTF1 and other transcription factors to deploy their transcriptional program. We identify NFIC as a NR5A2 interactor and regulator of acinar differentiation. NFIC binding sites are enriched in NR5A2 ChIP-Sequencing peaks. Nfic knockout mice have a smaller, histologically normal, pancreas with reduced acinar gene expression. NFIC binds and regulates the promoters of acinar genes and those involved in RNA/protein metabolism, and Nfic knockout pancreata show defective ribosomal RNA maturation. NFIC dampens the endoplasmic reticulum stress program through binding to gene promoters and is required for resolution of Tunicamycin-mediated stress. NFIC is down-regulated during caerulein pancreatitis and is required for recovery after damage. Normal human pancreata with low levels of NFIC transcripts display reduced expression of genes down-regulated in Nfic knockout mice. NFIC expression is down-regulated in mouse and human pancreatic ductal adenocarcinoma. Consistently, Nfic knockout mice develop a higher number of mutant Kras-driven pre-neoplastic lesions., This work was supported, in part, by grants SAF2011-29530, SAF2015-70553-R, RTI2018-101071-B-I00 from Ministerio de Ciencia, Innovación y Universidades (Madrid, Spain) (co-funded by the ERDF-EU) and RTICC from Instituto de Salud Carlos III (RD12/0036/0034) to FXR and grants PID2020-119533GB-I00, from Ministerio de Ciencia, Innovación y Universidades (Madrid, Spain), and GCB15152955MÉND, from the Spanish Association Against Cancer (AECC), to RM. I.C. was recipient of a Beca de Formación del Personal Investigador from Ministerio de Economía y Competitividad (Madrid, Spain). The research leading to these results has received funding from People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme (FP7/2007-2013) (REA grant agreement n° 608765”). S.P. was supported by a Juan de la Cierva Programme fellowship from Ministerio de Ciencia, Innovación y Universidades. C.B. is supported by a FPI Fellowship from Ministerio de Ciencia, Innovación y Universidades. I.M. was supported by a Fellowship from Fundació Bancària La Caixa (ID 100010434) (grant number LCF/BQ/ES18/11670009). CNIO is supported by Ministerio de Ciencia, Innovación y Universidades as a Centro de Excelencia Severo Ochoa SEV-2015-0510.